Here are three updates on spine medtech mergers and acquisitions since Feb. 28:
1. Bioventus may not acquire CartiHeal after all. The orthopedic medtech company reached a new settlement with former CartiHeal shareholders. Under the agreement, Bioventus could transfer back ownership to eliminate $350 million of deferred purchase price obligations and accrued interest.
2. Xtant Medical has acquired Surgalign's Coflex product line for $17 million. The acquisition strengthens Xtant's offerings and supports Surgalign's balance sheet as it focuses on digital health.